PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Frazier Healthcare Partners adds to Life Sciences Team

Frazier Healthcare Partners has appointed Mark Barrett as an Entrepreneur-in-Residence (EIR) in the firm’s Life Sciences team.

Most recently, Barrett served as Global Head of Strategy & Business Development at Sanofi Genzyme and was a member of the company’s executive leadership team responsible for managing Sanofi Genzyme’s global rare diseases, immunology, multiple sclerosis, and oncology businesses. Prior to Genzyme, Barrett held leadership positions in Johnson & Johnson’s business development group and helped launch the Johnson & Johnson Innovation Center in Boston.
 
“We have known Mark for many years and worked closely with him on the successful spin-out of Incline Therapeutics from J&J. We are thrilled to have him join our company creation efforts”
 
Barrett brings more than 15 years of leadership and biopharma industry expertise to his efforts to form new companies with Frazier. He is the founder and CEO of Yosemite Therapeutics, a newly formed search company focused on developing innovative treatments for serious diseases, and will be based in Boston.
 
“We have known Mark for many years and worked closely with him on the successful spin-out of Incline Therapeutics from J&J. We are thrilled to have him join our company creation efforts,” says Jamie Topper, Managing General Partner with the Frazier Life Sciences team.

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured